| 1,6-Naphthyridine-3-carboxylic acid, 4-(4-cyano-2-methoxyphenyl)-1,4-dihydro-5-methoxy-2,8-dimethyl- |
非奈利酮杂质10 |
2640280-86-8 |
| 4H-1-Benzopyran-4-one, 2-(4-methoxyphenyl)-5-[(3-methyl-2-buten-1-yl)oxy]-3,7-bis(phenylmethoxy)- |
淫羊藿苷杂质4 |
2136637-48-2 |
| Metronidazole EP impurity C |
甲硝唑杂质C |
5006-69-9 |
| SiMvastatin Hydroxy Acid Ethyl Ester |
辛伐他汀杂质 |
864357-87-9 |
| Carboxy Gliclazide |
羧基格列齐特 |
38173-52-3 |
| 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine |
托法替尼氢化杂质 |
1812890-23-5 |
| Moxifloxacin Related Compound A (HCl salt form) |
莫西沙星杂质A(盐酸盐) |
151282-23-4 |
| DesMethyl AMisulpride |
氨磺必利杂质B |
148516-54-5 |
| O-Desethyl Azilsartan |
阿齐沙坦杂质F |
1442400-68-1 |
| N-((R)-1-(((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide |
硼替佐米PTZM-3非对映异构体 |
1375004-39-9 |
| rel-(R,R)-Voriconazole |
rel-(R,R)-伏立康唑 |
137330-52-0 |
| BenzenesulfonaMide, 3-[4-[4-(aMinosulfonyl)phenyl]-5-Methyl-3-isoxazolyl]- |
3-[4-[4-(氨基磺酰基)苯基]-5-甲基-3-异恶唑基]苯磺酰胺 |
1373038-59-5 |
| Benzoic acid, 2-hydroxy-3-(2-phenyldiazenyl)- |
Benzoic acid, 2-hydroxy-3-(2-phenyldiazenyl)- |
136819-59-5 |
| Blonanserin Impurity 10 |
布南色林杂质10 |
132810-87-8 |
| 6β-Hydroxy MoMetasone Furoate |
6Β-羟基莫米松糠酸 |
132160-74-8 |
| 4-Desmethyl 3-Methyl Vortioxetine Hydrochloride |
4-Desmethyl 3-Methyl Vortioxetine Hydrochloride |
1293343-01-7 |
| Landiolol Hydrochloride EnantiomerⅢ（Benzenepropanoic acid, |
盐酸兰地洛尔异构体Ⅲ |
1253907-81-1 |
| Mono-POC Tenofovir 6-Isopropyl CarbaMate |
替诺福韦杂质E |
1244022-56-7 |
| 3-(3-hydroxypropyl)-7,8-dimethoxy-1,3-dihydro-2H-benzo[d]azepin-2-one |
伊伐布雷定杂质H |
1235547-06-4 |
| PSI-7976 |
索非布韦R-磷酸盐 |
1190308-01-0 |
